IMARK is a consortium created to combine the different modalities of biomarker discovery, tracing and detection in a single hub: from fluorescence microscopy to MRI to proteomics and more. As a consortium we are interested to pursue industrial collaborations, thereby broadening our portfolio and offering the expertise of teams with vast experience operating and running experiments in our state of the art facilities.

Examples from our combined portfolio of research includes peripheral neuropathies, aging, regeneration, neurodegenerative diseases, radiopharmaceuticals, human papilloma virus, glioblastoma and SARS-CoV-2. We are experienced with organoid and laboratory animal screening.

Thanks to our expertise, cultivated over decades of research, assembly of analysis and experimental pipelines is streamlined for our teams. If you have a biomarker related question, we are here to tailor the methodology and find the answer!